Sysmex America, Inc. Offers Live Demonstrations at AACC 2017

Hematology leader showcasing several newly-released products at booth 4819

News provided by

Aug 02, 2017, 10:32 ET

LINCOLNSHIRE, Ill., Aug. 2, 2017 /PRNewswire/ -- Sysmex America, Inc., (SAI) a leading provider of automated hematology and urinalysis diagnostic testing equipment, today announced they will feature product demonstrations at their booth. This year, SAI launched several key diagnostic instruments, with technology that is new to the United States market.

At booth 4819, SAI will showcase hematology products, including the XN-L hematology analyzers and BeyondCare^SM Quality Monitor program, Alifax ESR analyzer, XN-9100 automated hematology analyzers, XN-3100 automated hematology analyzers and XN-V Series^TMSoftware for Automated Hematology Analyzers specifically for scientific research.

The XN-L Series offers optional software licenses for (1) a reticulocyte channel to aid in anemia management, and (2) body fluid cell counts. For integrated health networks, common reagents and controls allow standardized testing from high volume core labs to affiliated clinics and physician office labs.

Sysmex expands its BeyondCare brand of industry-leading system and customer support with the introduction of BeyondCare Quality Monitor program. "BeyondCare Quality Monitor program, a Sysmex proprietary innovation, is a leading-edge, evidence-based QC and calibration verification management program that partners Sysmex with the laboratory to proactively monitor quality assurance metrics. It will be standard on all XN-L hematology analyzers," said Andy Hay, COO Sysmex America.

The XN-V Series^TMSoftware for Automated Hematology Analyzers for scientific research includes specialized software to test a broad range of laboratory animal species, including mouse, rat, non-human primate, cattle, plus other species and sub-species. In addition to the pre-loaded species, the software is customizable with manual gating for each parameter which allows for the creation of other protocols.

About Sysmex America, Inc.

Sysmex America, Inc. distributes and supports a diverse portfolio of best-in-class, in vitro diagnostic hematology and clinical laboratory products in the U.S., Canada and Latin America. It is the U.S. headquarters of Sysmex Corporation, located in Kobe, Japan, a trusted world leader in clinical laboratory solutions that optimize efficiency, operations and financial performance in the lab. Sysmex is reshaping the healthcare of tomorrow at the clinical laboratory level by transcending the boundaries of diagnostic science and serving as the pulse of reliable, accountable care. For more information about Sysmex America, visit www.sysmex.com/us.

SOURCE Sysmex America, Inc.